Home » Resources » Patents
  • Long-term licence agreement for the development of EYEPRIM®, OPIA Technologies' main device platform in animal studies. As part of the agreement, Iris Pharma has the exclusive licence for the use of EYEPRIM® device to perform ocular surface biopsies of the living eye in its preclinical research activities. April, 2011
  • Apparatus and method for treating corneal neovascularization or blood vessel accumulation on the conjunctiva. PCT Filing Date: Jan. 10, 2005